文献速递心脑血管急症

自然与手术过早绝经与心血管疾病发病的关系

Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease.
PubMed 文献 · JAMA · 2019-01-01
一句话结论40岁前自然或手术绝经与绝经后女性心血管疾病复合终点风险小幅但显著升高相关,手术绝经风险更高。

该研究基于英国生物银行队列,纳入144 260名40-69岁绝经后女性,随访中位7年,比较40岁前自然过早绝经(4904例)和手术过早绝经(644例)与无过早绝经者(参考组)的心血管疾病复合终点。主要终点包括冠心病、心力衰竭、主动脉瓣狭窄、二尖瓣反流、心房颤动、缺血性卒中、外周动脉疾病和静脉血栓栓塞。自然过早绝经组主要终点发生率为8.78/1000人年,手术过早绝经组为11.27/1000人年,参考组为5.70/1000人年。校正传统心血管危险因素和绝经激素治疗后,自然和手术过早绝经的风险比分别为1.36和1.87。

要点

  • 40岁前自然过早绝经者主要心血管复合终点风险较无过早绝经者升高(HR 1.36,95%CI 1.19-1.56)。
  • 40岁前手术过早绝经者主要心血管复合终点风险更高(HR 1.87,95%CI 1.36-2.58)。
  • 自然过早绝经组主要终点发生率8.78/1000人年,较参考组5.70/1000人年增加3.08/1000人年(95%CI 2.06-4.10)。
  • 手术过早绝经组主要终点发生率11.27/1000人年,较参考组增加5.57/1000人年(95%CI 2.41-8.73)。
  • 该关联在绝经后女性中幅度较小但具统计学显著性,需进一步研究机制。

适用人群与场景

  • 英国生物银行队列中2006-2010年招募的40-69岁、入组时已绝经的女性,共144 260名符合纳入标准。
  • 暴露组为40岁前自然过早绝经(无卵巢切除)或40岁前双侧卵巢切除的手术过早绝经;参考组为无过早绝经的绝经后女性。

诊断标准与关键阈值

  • 自然过早绝经:40岁前绝经且无卵巢切除。
  • 手术过早绝经:40岁前双侧卵巢切除。

研究设计与关键结果

  • 研究类型为队列研究(英国生物银行),纳入144 260名绝经后女性,平均(SD)入组年龄59.9(5.4)岁;自然过早绝经4904例(3.4%),手术过早绝经644例(0.4%)。
  • 随访中位7年(四分位距6.3-7.7),主要终点为冠心病、心力衰竭、主动脉瓣狭窄、二尖瓣反流、心房颤动、缺血性卒中、外周动脉疾病和静脉血栓栓塞的复合终点。
  • 主要终点发生率:无过早绝经组5.70/1000人年(5415例,3.9%),自然过早绝经组8.78/1000人年(292例,6.0%),手术过早绝经组11.27/1000人年(49例,7.6%)。
  • 自然过早绝经组与无过早绝经组主要终点发生率差值+3.08/1000人年(95%CI 2.06-4.10;P < .001);手术过早绝经组差值+5.57/1000人年(95%CI 2.41-8.73;P < .001)。
  • 校正传统心血管危险因素和绝经激素治疗后,自然过早绝经主要终点HR 1.36(95%CI 1.19-1.56;P < .001),手术过早绝经HR 1.87(95%CI 1.36-2.58;P < .001)。
  • 次要终点包括主要终点的各单独组分、新发高血压、高脂血症和2型糖尿病(摘要未报告具体结果)。

证据类型、等级与局限

  • 证据类型:队列研究(英国生物银行)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于40岁前自然或手术绝经的绝经后女性,应知晓其心血管疾病复合终点风险较无过早绝经者小幅但显著升高(自然HR 1.36,手术HR 1.87)。
  • 近期指南支持使用40岁前绝经史来细化中年女性动脉粥样硬化性心血管疾病风险评估。
  • 作者认为需进一步研究以理解这些关联的机制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Recent guidelines endorse using history of menopause before age 40 years to refine atherosclerotic cardiovascular disease risk assessments among middle-aged women. Robust data on cardiovascular disease risk in this population are lacking.

OBJECTIVE: To examine the development of cardiovascular diseases and cardiovascular risk factors in women with natural and surgical menopause before age 40 years.

DESIGN, SETTING, AND PARTICIPANTS: Cohort study (UK Biobank), with adult residents of the United Kingdom recruited between 2006 and 2010. Of women who were 40 to 69 years old and postmenopausal at study enrollment, 144 260 were eligible for inclusion. Follow-up occurred through August 2016.

EXPOSURES: Natural premature menopause (menopause before age 40 without oophorectomy) and surgical premature menopause (bilateral oophorectomy before age 40). Postmenopausal women without premature menopause served as the reference group.

MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of incident coronary artery disease, heart failure, aortic stenosis, mitral regurgitation, atrial fibrillation, ischemic stroke, peripheral artery disease, and venous thromboembolism. Secondary outcomes included individual components of the primary outcome, incident hypertension, hyperlipidemia, and type 2 diabetes.

RESULTS: Of 144 260 postmenopausal women included (mean [SD] age at enrollment, 59.9 [5.4] years), 4904 (3.4%) had natural premature menopause and 644 (0.4%) had surgical premature menopause. Participants were followed up for a median of 7 years (interquartile range, 6.3-7.7). The primary outcome occurred in 5415 women (3.9%) with no premature menopause (incidence, 5.70/1000 woman-years), 292 women (6.0%) with natural premature menopause (incidence, 8.78/1000 woman-years) (difference vs no premature menopause, +3.08/1000 woman-years [95% CI, 2.06-4.10]; P < .001), and 49 women (7.6%) with surgical premature menopause (incidence, 11.27/1000 woman-years) (difference vs no premature menopause, +5.57/1000 woman-years [95% CI, 2.41-8.73]; P < .001). For the primary outcome, natural and surgical premature menopause were associated with hazard ratios of 1.36 (95% CI, 1.19-1.56; P < .001) and 1.87 (95% CI, 1.36-2.58; P < .001), respectively, after adjustment for conventional cardiovascular disease risk factors and use of menopausal hormone therapy.

CONCLUSIONS AND RELEVANCE: Natural and surgical premature menopause (before age 40 years) were associated with a small but statistically significant increased risk for a composite of cardiovascular diseases among postmenopausal women. Further research is needed to understand the mechanisms underlying these associations.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Honigberg MC, Zekavat SM, Aragam K, et al. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA. 2019. PMID: 31738818. doi:10.1001/jama.2019.19191

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。